BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30266836)

  • 1. Overexpression of
    Lee KKL; Peskett E; Quinn CM; Aiello R; Adeeva L; Moulding DA; Stanier P; Pauws E
    Dis Model Mech; 2018 Nov; 11(11):. PubMed ID: 30266836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further analysis of the Crouzon mouse: effects of the FGFR2(C342Y) mutation are cranial bone-dependent.
    Liu J; Nam HK; Wang E; Hatch NE
    Calcif Tissue Int; 2013 May; 92(5):451-66. PubMed ID: 23358860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGFR2c-mediated ERK-MAPK activity regulates coronal suture development.
    Pfaff MJ; Xue K; Li L; Horowitz MC; Steinbacher DM; Eswarakumar JVP
    Dev Biol; 2016 Jul; 415(2):242-250. PubMed ID: 27034231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific responses to aberrant FGF signaling in complex head phenotypes.
    Martínez-Abadías N; Motch SM; Pankratz TL; Wang Y; Aldridge K; Jabs EW; Richtsmeier JT
    Dev Dyn; 2013 Jan; 242(1):80-94. PubMed ID: 23172727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The craniofacial phenotype of the Crouzon mouse: analysis of a model for syndromic craniosynostosis using three-dimensional MicroCT.
    Perlyn CA; DeLeon VB; Babbs C; Govier D; Burell L; Darvann T; Kreiborg S; Morriss-Kay G
    Cleft Palate Craniofac J; 2006 Nov; 43(6):740-8. PubMed ID: 17105336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis.
    Eswarakumar VP; Horowitz MC; Locklin R; Morriss-Kay GM; Lonai P
    Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12555-60. PubMed ID: 15316116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synchondrosis fusion contributes to the progression of postnatal craniofacial dysmorphology in syndromic craniosynostosis.
    Hoshino Y; Takechi M; Moazen M; Steacy M; Koyabu D; Furutera T; Ninomiya Y; Nuri T; Pauws E; Iseki S
    J Anat; 2023 Mar; 242(3):387-401. PubMed ID: 36394990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic background dependent modifiers of craniosynostosis severity.
    Dudakovic A; Nam HK; Wijnen AJV; Hatch NE
    J Struct Biol; 2020 Dec; 212(3):107629. PubMed ID: 32976998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meckel's Cartilage in Mandibular Development and Dysmorphogenesis.
    Pitirri MK; Durham EL; Romano NA; Santos JI; Coupe AP; Zheng H; Chen DZ; Kawasaki K; Jabs EW; Richtsmeier JT; Wu M; Motch Perrine SM
    Front Genet; 2022; 13():871927. PubMed ID: 35651944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis.
    Eswarakumar VP; Ozcan F; Lew ED; Bae JH; Tomé F; Booth CJ; Adams DJ; Lax I; Schlessinger J
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18603-8. PubMed ID: 17132737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Fgfr2 W290R mouse model of Crouzon syndrome.
    Gong SG
    Childs Nerv Syst; 2012 Sep; 28(9):1495-503. PubMed ID: 22872266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Craniosynostosis-associated Fgfr2(C342Y) mutant bone marrow stromal cells exhibit cell autonomous abnormalities in osteoblast differentiation and bone formation.
    Liu J; Kwon TG; Nam HK; Hatch NE
    Biomed Res Int; 2013; 2013():292506. PubMed ID: 23762837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dysmorphic mouse model reveals developmental interactions of chondrocranium and dermatocranium.
    Motch Perrine SM; Pitirri MK; Durham EL; Kawasaki M; Zheng H; Chen DZ; Kawasaki K; Richtsmeier JT
    Elife; 2022 Jun; 11():. PubMed ID: 35704354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant bony vasculature associated with activating fibroblast growth factor receptor mutations accompanying Crouzon syndrome.
    Tholpady SS; Abdelaal MM; Dufresne CR; Gampper TJ; Lin KY; Jane JA; Morgan RF; Ogle RC
    J Craniofac Surg; 2004 May; 15(3):431-5; discussion 436-8. PubMed ID: 15111803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dura in the pathogenesis of syndromic craniosynostosis: fibroblast growth factor receptor 2 mutations in dural cells promote osteogenic proliferation and differentiation of osteoblasts.
    Ang BU; Spivak RM; Nah HD; Kirschner RE
    J Craniofac Surg; 2010 Mar; 21(2):462-7. PubMed ID: 20489451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGFR2 mutation in 46,XY sex reversal with craniosynostosis.
    Bagheri-Fam S; Ono M; Li L; Zhao L; Ryan J; Lai R; Katsura Y; Rossello FJ; Koopman P; Scherer G; Bartsch O; Eswarakumar JV; Harley VR
    Hum Mol Genet; 2015 Dec; 24(23):6699-710. PubMed ID: 26362256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of tissue-non-specific alkaline phosphatase gene therapy on craniosynostosis and craniofacial morphology in the FGFR2C342Y/+ mouse model of Crouzon craniosynostosis.
    Wang E; Nam HK; Liu J; Hatch NE
    Orthod Craniofac Res; 2015 Apr; 18 Suppl 1(0 1):196-206. PubMed ID: 25865549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGFR2 Mutation p.Cys342Arg Enhances Mitochondrial Metabolism-Mediated Osteogenesis via FGF/FGFR-AMPK-Erk1/2 Axis in Crouzon Syndrome.
    Wang Y; Liu Y; Chen H; Liu X; Zhang Y; Wang Y; Gu Y
    Cells; 2022 Oct; 11(19):. PubMed ID: 36231091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-Phenotype Correlation of Tracheal Cartilaginous Sleeves and Fgfr2 Mutations in Mice.
    Lam AS; Liu CC; Deutsch GH; Rivera J; Perkins JA; Holmes G; Jabs EW; Cunningham ML; Dahl JP
    Laryngoscope; 2021 Apr; 131(4):E1349-E1356. PubMed ID: 32886384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minor Suture Fusion in Syndromic Craniosynostosis.
    Runyan CM; Xu M D W; Alperovich M; Massie M D JP; Paek G; Cohen BA; Staffenberg DA; Flores RL; Taylor JA
    Plast Reconstr Surg; 2017 Sep; 140(3):434e-445e. PubMed ID: 28574949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.